Skip to content
10-K

Annual Report

CADENCE PHARMACEUTICALS INC

0001193125-14-077365

← back to feed
Filed
Feb 28, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Feb 21, 2014 89.18M sh
Capex FY 2013 · Dec 31, 2013 $505K
Capex FY 2013 · Dec 31, 2012 $1.71M
Capex FY 2013 · Dec 31, 2011 $2.73M
Operating Cash Flow FY 2013 · Dec 31, 2013 −$23.19M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$64.3M
Operating Cash Flow FY 2013 · Dec 31, 2011 −$78.15M
Long Term Debt FY 2013 · Dec 31, 2013 $18.54M
Long Term Debt FY 2013 · Dec 31, 2012 $28.82M
Short Term Debt FY 2013 · Dec 31, 2013 $10.78M
Cash And Equivalents FY 2013 · Dec 31, 2013 $55.08M
Cash And Equivalents FY 2013 · Dec 31, 2012 $58.33M
Cash And Equivalents FY 2013 · Dec 31, 2011 $82.61M
Cash And Equivalents FY 2013 · Dec 31, 2010 $112.18M
Stockholders Equity FY 2013 · Dec 31, 2013 $34.88M
Stockholders Equity FY 2013 · Dec 31, 2012 $47.81M
Stockholders Equity FY 2013 · Dec 31, 2011 $119.31M
Stockholders Equity FY 2013 · Dec 31, 2010 $123.96M
Current Liabilities FY 2013 · Dec 31, 2013 $36.54M
Current Liabilities FY 2013 · Dec 31, 2012 $21M
Total Liabilities FY 2013 · Dec 31, 2013 $55.93M
Total Liabilities FY 2013 · Dec 31, 2012 $49.87M
Current Assets FY 2013 · Dec 31, 2013 $77.89M
Current Assets FY 2013 · Dec 31, 2012 $76.52M
Total Assets FY 2013 · Dec 31, 2013 $90.8M
Total Assets FY 2013 · Dec 31, 2012 $97.68M
Sga Expense FY 2013 · Dec 31, 2013 $94.48M
Sga Expense FY 2013 · Dec 31, 2012 $86.84M
Sga Expense FY 2013 · Dec 31, 2011 $81.5M
Rd Expense FY 2013 · Dec 31, 2013 $6.74M
Rd Expense FY 2013 · Dec 31, 2012 $6.52M
Rd Expense FY 2013 · Dec 31, 2011 $8.89M
Net Income FY 2013 · Dec 31, 2013 −$4.12M
Net Income FY 2013 · Dec 31, 2013 −$24.29M
Net Income FY 2013 · Sep 30, 2013 −$6.94M
Net Income FY 2013 · Jun 30, 2013 −$11.88M
Net Income FY 2013 · Mar 31, 2013 −$1.36M
Net Income FY 2013 · Dec 31, 2012 −$21.42M
Net Income FY 2013 · Dec 31, 2012 −$80.97M
Net Income FY 2013 · Sep 30, 2012 −$15.89M
Net Income FY 2013 · Jun 30, 2012 −$20.99M
Net Income FY 2013 · Mar 31, 2012 −$22.67M
Net Income FY 2013 · Dec 31, 2011 −$93.02M
Operating Income FY 2013 · Dec 31, 2013 −$27.54M
Operating Income FY 2013 · Dec 31, 2012 −$76.67M
Operating Income FY 2013 · Dec 31, 2011 −$88.74M
Gross Profit FY 2013 · Dec 31, 2013 $23.77M
Gross Profit FY 2013 · Dec 31, 2013 $74.58M
Gross Profit FY 2013 · Sep 30, 2013 $18.99M
Gross Profit FY 2013 · Jun 30, 2013 $16.38M
Gross Profit FY 2013 · Mar 31, 2013 $15.45M
Gross Profit FY 2013 · Dec 31, 2012 $10M
Gross Profit FY 2013 · Dec 31, 2012 $26.93M
Gross Profit FY 2013 · Sep 30, 2012 $7.82M
Gross Profit FY 2013 · Jun 30, 2012 $5.35M
Gross Profit FY 2013 · Mar 31, 2012 $3.76M
Cost Of Revenue FY 2013 · Dec 31, 2013 $37.97M
Cost Of Revenue FY 2013 · Dec 31, 2012 $23.26M
Cost Of Revenue FY 2013 · Dec 31, 2011 $12.41M
Revenue FY 2013 · Dec 31, 2013 $35.31M
Revenue FY 2013 · Dec 31, 2013 $112.56M
Revenue FY 2013 · Sep 30, 2013 $28.96M
Revenue FY 2013 · Jun 30, 2013 $24.67M
Revenue FY 2013 · Mar 31, 2013 $23.61M
Revenue FY 2013 · Dec 31, 2012 $17.17M
Revenue FY 2013 · Dec 31, 2012 $50.18M
Revenue FY 2013 · Sep 30, 2012 $13.9M
Revenue FY 2013 · Jun 30, 2012 $11.11M
Revenue FY 2013 · Mar 31, 2012 $8M
Revenue FY 2013 · Dec 31, 2011 $16.7M